Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Unapproved or misbranded drugs

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified.

309 FDA drug recalls with this cause, newest first.

Every prescription drug and most over-the-counter drugs sold in the US need either an approved application (an NDA or ANDA) or must fit an OTC monograph. A product that skips both is pulled regardless of whether anything is physically wrong with it, because its dose, purity and claims were never checked. Typical cases: compounded products sold at commercial scale, imported drugs not cleared for the US, and products whose labeling makes claims that turn them into unapproved new drugs. Supplements that turn out to contain a hidden prescription drug are filed under chemical contamination and hidden ingredients instead.

Class II · Moderate risk

Age Stop Ex

CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Terminated Unapproved drug Herbal Doctor Remedies D-1109-2020
Class II · Moderate risk

Age Back

CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Terminated Unapproved drug Herbal Doctor Remedies D-1108-2020
Class II · Moderate risk

Acne Off

CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Terminated Unapproved drug Herbal Doctor Remedies D-1107-2020
Class II · Moderate risk

Acne Cystic

CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Terminated Unapproved drug Herbal Doctor Remedies D-1106-2020
Class II · Moderate risk

Acupuncture

CGMP Deviations: These products have been found to be misbranded as unapproved new drugs

Terminated Unapproved drug Herbal Doctor Remedies D-1105-2020
Class II · Moderate risk

Kushim Tablets

Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

Terminated Unapproved drug B and a Trading Corporation D-0840-2020
Class II · Moderate risk

Entropic Labs SARM RAD-140

Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)

Terminated Unapproved drug Tuscano and Delucia Group (DBA Entropic Labs) D-0800-2020
Class II · Moderate risk

LA FRESH travel lite Sunnyside Lotion Wipe silky

Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.

Terminated Unapproved drug La Fresh Group, Inc. D-1566-2019
Class III · Low risk

ATHLETICARE Anti-Bacterial Hand Soap AC 550

Does Not Meet Monograph: product contains, triclosan, an ingredient that can no longer be contained in over-the-counter consumer antiseptic/antibacterial wash products.

Terminated Unapproved drug Petra Hygienic Systems Int Ltd NDC 42326-550-01 D-0994-2019